Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma

Table 4 Patients’ characteristics and survival according to treatment

	Becker et al	Kamada [26]	Bartolozzi [27]	Tanaka [28]	Koda [29]	Yamamoto [20]
Number of patients
	52	69	53	43	36	100
Cause of cirrhosis
Hepatitis:alcohol	14:25	65	5:48	No data	No data	100
1-yr survival in % of patients
TACE+PEI	62	90	100	100	1001	95
TACE	63	86	92.6	68	751	92.5
2-yr survival in % of patients
TACE+PEI	39	3-yr:65	86.7	85	822	72.5
TACE	18	3-yr:44	69.7	37	502	57.5
P	NS (0.371)	NS	NS	<0.001	<0.05	<0.05

¹Observation period only 10 mo. 2Observation period only 20 mo.